| J01DB05 |
Cefadroxil |
J01DB05 Cefadroxil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DB05 |
Cefadroxil |
Biodroxil |
Powder for oral suspension |
250 mg/ 5 ml - 60 ml |
mg |
1 |
Sandoz GmbH, Австрия |
2000 |
mg |
- |
6.47 |
4.31333 |
6.47 |
25% |
1.62 |
за деца до 8 г. |
A38,H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-1930/27.11.2013; НСР-2282/13.01.2014 |
16.02.2014 |
08.09.2012 |
|
Заличен |
2327 |
| J01DB05 |
Cefadroxil |
Valdocef |
Granules for oral suspension |
250 mg/5 ml |
mg |
1 x 100 ml |
Alkaloid – INT d.o.o., Словения |
2000 |
mg |
- |
10.2 |
4.08 |
10.2 |
25% |
2.55 |
за деца до 8 г. |
J03.0,J03.8,J03.9,N10,N11.0,N11.1,N11.8 |
НСР-4724/26.09.2014; НСР-5348/18.12.2014. |
16.01.2015 |
|
|
Заличен |
3173 |
| J01DC02 |
Cefuroxime |
J01DC02 Cefuroxime |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DC02 |
Cefuroxime |
AKSEF |
Film coated tablet |
500 |
mg |
20 |
Нобел Фарма ЕООД, България |
500 |
mg |
- |
23.72 |
1.186 |
23.72 |
25% |
5.93 |
|
N10,N11.0,N11.1,N11.8 |
НСР-12714/19.05.2017(допуска предварително изпълнение); НСР-18086/01.03.2019 |
02.04.2019 |
|
|
Заличен |
3152 |
| J01DC02 |
Cefuroxime |
AKSEF 500 |
Film coated tablet |
500 |
mg |
20 |
Нобел Фарма ЕООД, България |
500 |
mg |
- |
23.72 |
1.186 |
23.72 |
25% |
5.93 |
|
N10,N11.0,N11.1,N11.8 |
№ 25/ 03.08.2009; № 29/ 10.08.2009; № 141/ 24.01.2011; КЦРР-1334/24.08.2012 г.; КЦРР-1976/10.01.2013 г; НСР-4449/15.08.2014; HCP-9250/05.05.2016; НСР-12231/03.04.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
3152 |
| J01DC02 |
Cefuroxime |
Lifurox |
Film coated tablet |
500 |
mg |
10 |
Чайкафарма Висококачествените лекарства АД, България |
500 |
mg |
- |
23.72 |
1.186 |
11.86 |
25% |
2.96 |
|
N10,N11.0,N11.1,N11.8 |
№ 177/ 21.06.2011; КЦPP-582/04.05.2012 г.; HCP-9249/05.05.2016; НСР-16409/09.08.2018; НСР-18087/01.03.2019 |
02.04.2019 |
08.09.2012 |
|
Заличен |
909 |
| J01DC02 |
Cefuroxime |
Lifurox |
Film coated tablet |
250 |
mg |
10 |
Чайкафарма Висококачествените лекарства АД, България |
500 |
mg |
- |
18.6 |
1.186 |
5.93 |
25% |
1.48 |
|
N10,N11.0,N11.1,N11.8 |
№ 145/ 28.01.2011; КЦPP-582/04.05.2012 г.; HCP-9249/05.05.2016; НСР-12161/27.03.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
908 |
| J01DC04 |
Cefaclor |
J01DC04 Cefaclor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DC04 |
Cefaclor |
CEFACLOR ALKALOID |
Capsule, hard |
500 |
mg |
16 |
Алкалоид ЕООД, България |
1000 |
mg |
- |
23.33 |
2.91625 |
23.33 |
25% |
5.83 |
|
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-7279/29.10.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
110 |
| J01DC04 |
Cefaclor |
MEDOCLOR |
Capsule, hard |
500 |
mg |
16 |
Medochemie Ltd., Кипър |
1000 |
mg |
- |
22.4 |
2.8 |
22.4 |
25% |
5.6 |
|
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-3666/06.06.2014; НСР-4518/22.08.2014 |
16.09.2014 |
08.09.2012 |
|
Заличен |
2885 |
| J01DC04 |
Cefaclor |
MEDOCLOR |
Capsule, hard |
250 |
mg |
16 |
Medochemie Ltd., Кипър |
1000 |
mg |
- |
11.1 |
2.57 |
10.28 |
25% |
2.57 |
|
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-3472/16.05.2014 |
16.06.2014 |
08.09.2012 |
|
Заличен |
466 |
| J01DC04 |
Cefaclor |
J01DC04 Cefaclor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DC04 |
Cefaclor |
CEC |
Powder for oral suspension |
125 mg/5 ml - 100 ml |
mg |
1 |
Hexal AG, Германия |
1000 |
mg |
- |
7.72 |
2.684 |
6.71 |
25% |
1.68 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
КЦРР-836/15.06.2012 г.; НСР-2246/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
1265 |
| J01DC04 |
Cefaclor |
CEC forte |
Powder for oral suspension |
250 mg/ 5 ml - 100 ml |
mg |
1 |
Hexal AG, Германия |
1000 |
mg |
- |
13.42 |
2.684 |
13.42 |
25% |
3.36 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
КЦРР-836/15.06.2012 г.; НСР-2245/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
1267 |
| J01DC04 |
Cefaclor |
CEFACLOR ALKALOID |
Granules for oral suspension |
250 mg/5 ml - 60 ml |
mg |
1 |
Алкалоид ЕООД, България |
1000 |
mg |
- |
11.03 |
3.67667 |
11.03 |
25% |
2.76 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-7283/29.10.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
112 |
| J01DC04 |
Cefaclor |
CEFACLOR ALKALOID |
Granules for oral suspension |
125 mg/5 ml - 60 ml |
mg |
1 |
Алкалоид ЕООД, България |
1000 |
mg |
- |
7.28 |
3.67667 |
5.52 |
25% |
1.38 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-7281/29.10.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
111 |
| J01DC04 |
Cefaclor |
MEDOCLOR |
Granules for oral suspension |
125 mg/5 ml - 100 ml |
mg |
1 |
Medochemie Ltd., Кипър |
1000 |
mg |
- |
11.63 |
3.67667 |
9.19 |
25% |
2.3 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-3666/06.06.2014; НСР-4518/22.08.2014 |
16.09.2014 |
08.09.2012 |
|
Заличен |
2886 |
| J01DC04 |
Cefaclor |
MEDOCLOR FORTE |
Granules for oral suspension |
250 mg/5 ml - 100 ml |
mg |
1 |
Medochemie Ltd., Кипър |
1000 |
mg |
- |
20.58 |
3.67667 |
18.38 |
25% |
4.6 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,J42,N10,N11.0,N11.1,N11.8 |
НСР-3666/06.06.2014; НСР-4518/22.08.2014 |
16.09.2014 |
08.09.2012 |
|
Заличен |
2887 |
| J01DC10 |
Cefprozil |
J01DC10 Cefprozil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DC10 |
Cefprozil |
CEFZIL |
Powder for oral suspension |
250 mg/5 ml - 60 ml |
mg |
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
1000 |
mg |
- |
16.78 |
5.59333 |
16.78 |
25% |
4.19 |
за деца до 8 години |
A38,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,N10,N11.0,N11.1,N11.8 |
НСР-944/12.08.2013; НСР-3658/29.05.2014; НСР-5652/18.02.2015; НСР-9422/01.06.2016 |
02.07.2016 |
08.09.2012 |
|
Заличен |
3637 |
| J01DC10 |
Cefprozil |
CEFZIL |
Powder for oral suspension |
125 mg/5 ml - 60 |
ml |
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
1000 |
mg |
- |
14.72 |
5.59333 |
8.39 |
25% |
2.09 |
за деца до 8 години |
A38,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,N10,N11.0,N11.1,N11.8 |
НСР-944/12.08.2013; НСР-9423/01.06.2016 |
02.07.2016 |
08.09.2012 |
|
Заличен |
468 |
| J01DC10 |
Cefprozil |
J01DC10 Cefprozil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01DC10 |
Cefprozil |
CEFZIL |
Film coated tablet |
250 |
mg |
20 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
1000 |
mg |
- |
43.91 |
8.782 |
43.91 |
25% |
10.98 |
|
A38,J03.0,J03.8,J03.9,J15.0,J15.2,J15.3,J15.4,J15.5,J15.6,J15.8,J16.8,J40,N10,N11.0,N11.1,N11.8 |
НСР-944/12.08.2013; НСР-6049/16.04.2015. |
16.05.2015 |
08.09.2012 |
|
Заличен |
470 |
| J01DD08 |
Cefixime |
J01DD08 Cefixime |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|